Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, like the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use – and failure to do so may be grounds for compensation. Our lawyers are operating hard to acquire these hurt by the drug the compensation they may be entitled to.
Although bleeding is actually a frequent complication associated with anticoagulants, it has been alleged that Xarelto is much more unsafe than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, individuals may possibly be at risk for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging.
If you or perhaps a loved one suffered a severe bleeding occasion right after taking Xarelto, you might have legal recourse. For far more data, speak to us right now to have your case reviewed, totally free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in instances of death, funeral expenditures. Additionally, they are searching for punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of xarelto administration marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for far more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.